EDARADD Antikörper (AA 1-100) (HRP)
Kurzübersicht für EDARADD Antikörper (AA 1-100) (HRP) (ABIN6987531)
Target
Alle EDARADD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-100
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat,Dog,Cow,Sheep,Pig,Horse,Chicken
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human EDARADD
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- EDARADD (EDAR-Associated Death Domain (EDARADD))
-
Andere Bezeichnung
- EDARADD
-
Hintergrund
-
Synonyms: Cr, Crinkled homolog, ectodysplasia A receptor associated death domain, Ectodysplasin-A receptor-associated adapter protein, ED3, EDA3, EDAD_HUMAN, EDAR associated death domain, EDAR-associated death domain protein, EDARADD, Protein crinkled homolog.
Background: Adapter protein that interacts with EDAR DEATH domain and couples the receptor to EDA signaling pathway during morphogenesis of ectodermal organs. Mediates the activation of NF-kappa-B.
-
Gen-ID
- 128178
-
UniProt
- Q8WWZ3
-
Pathways
- Ubiquitin Proteasome Pathway
Target
-